Cytokine Gene and CD25 Antigen Expression by Peripheral Blood T Cells from Patients with Primary Sjögren's Syndrome

References

• Skopouli F. N., Dorsos A. A., Papaioannu T., Moutsopoulos H. M. Preliminary diagnostic criteria for Sjögren's syndrome. Scand. J. Rheumatol. 1986; 61: 22–25, Suppl.
   Google Scholar
• Fox R. I., Kang H ‐I. Pathogenesis of Sjögren's syndrome. Rheum. Dis. Clin. North Am. 1992; 18: 517–538
   PubMed Web of Science ®Google Scholar
• Youinou P., Mackenzie L., Ie Masson G., Papadopoulos N. M., Jouquan J., Pennec Y. L., Angelidis P., Katsikis P., Moutsopoulos H. M., Lydyard P. M. CD5‐expressing B lymphocytes in the blood and salivary glands of patients with Primary Sjögren's syndrome. J. Autoimmun. 1988; 1: 185–194
   PubMed Web of Science ®Google Scholar
• Aziz K. E., McCluskey P. J., Wakefield D. Phenotypic and functional abnormalities in the peripheral blood T‐cells of patients with Primary Sjögren's syndrome. Cytometry 1994; 18: 35–41
   PubMedGoogle Scholar
• Ichikawa Y., Shimizu H., Yoshida M., Arimori S. Accessory Molecules expressed on the peripheral blood or synovial fluid T lymphocytes from patients with Sjögren's syndrome or rheumatoid arthritis. Clin. Exp. Rheumatol. 1992; 10: 447–454
   Google Scholar
• Jamin C., Lamour A., Pennec L., Him M., Le Goff P., Youinou P. Expression of CD5 and CD72 on T and B cells subsets in rheumatoid arthritis and Sjögren's syndrome. Clin. Exp. Immunol. 1993; 92: 245–250
   Google Scholar
• Melendro E. L., Saldate C., Rivero S., Alarcón‐Segovia D. T cell subpopulations in the peripheral blood of patients with connective tissue diseases as determined by flow cytometry using monoclonal antibodies. Clin. Immunol. Immunopathol. 1983; 27: 340–347
   Google Scholar
• Sato K., Miyasaka N., Yamaoka K., Okuda M., Yata J., Nishioka K. Quantitative defect of CD4 + 2H4 + cells in systemic lupus erythematosus and Sjögren's syndrome. Arthritis. Rheum. 1987; 30: 1407–1411
   PubMed Web of Science ®Google Scholar
• Ichikawa Y., Shimizu M., Arimori S. Activation antigens expressed on T‐cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis. Clin. Exp. Rheumatol. 1990; 8: 243–249
   PubMed Web of Science ®Google Scholar
• Ichikawa Y., Shimizu H., Yoshida M., Arimori S. Activation of T cell subsets in the peripheral blood of patients with Sjögren's syndrome. Multicolor flow cytometric analysis. Arthritis. Rheum. 1990; 33: 1674–1681
   PubMed Web of Science ®Google Scholar
• Struyf N. J., Snoeck H. W., Bridts C. H., De Clerck L. S., Stevens W. J. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin‐2 and correlation with immune complexes. Ann. Rheum. Dis. 1990; 49: 690–693
   Google Scholar
• Gerli R., Bertotto A., Agea E., Lanfrancone L., Cernetti C., Spinozzi F., Rambotti P. Basis for defective proliferation of peripheral blood T cells to anti‐CD2 antibodies in priamry Sjögren's syndrome. J. Clin. Invest. 1990; 86: 1870–1877
   Google Scholar
• Llorente L., Richaud‐Patin Y., Fior R., Alcocer‐Varela J., Wijdenes J., Fourrier Morel B., Galanaud P., Emilie D. In vivo production of interleukin‐10 by non‐T cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus. Arthritis Rheum. 1994; 37: 1647–1655
   PubMed Web of Science ®Google Scholar
• Al‐Janadi M., Al‐Balla S., Al‐Dalaan A., Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J. Clin. Immunol. 1993; 13: 58–67
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control: Guidelines for the Performance of CD4 + T‐cell determinations in persons with human immunodeficiency virus infection. MMWR RR‐8 1992; Vol. 42
   Google Scholar
• Loken M., Brosnan J., Bach B., Ault K. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990; 11: 453–458
   PubMedGoogle Scholar
• Brain P., Gordon J., Willets W. Rosette formation by peripheral lymphocytes. Clin. Exp. Immunol. 1970; 6: 681–688
   PubMed Web of Science ®Google Scholar
• Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J. Exp. Med. 1972; 136: 207–215
   PubMed Web of Science ®Google Scholar
• Roumm A. D., Whiteside T. L., Mesdger T. A., Rodman A. P. Lymphocyte in the skin of patients with progressive systemic sclerosis. Quantification, subtyping and clinical correlations. Arthritis. Rheum. 1984; 27: 645–653
   PubMed Web of Science ®Google Scholar
• Ferrarini M., Steen V., Mesdger T. A., Whiteside T. L. Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis. Clin. Exp. Immunol. 1990; 79: 346–352
   PubMed Web of Science ®Google Scholar
• Rutenfranz I., Kruse A., Kirchner H. In situ hybridization of interferon‐gamma producing peripheral blood mononuclear cells. Scan. J. Immunol. 1991; 34: 169–178
   Google Scholar
• Maurer D., Felzman T., Holter W., Petera P., Smolen J., Knapp W. Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clin. Exp. Immunol. 1992; 87: 429–434
   PubMedGoogle Scholar
• Gauchat J. F., Gauchat D., De Weck A. L., Stadler B. M. Cytokine mRNA levels in antigen‐stimulated peripheral blood mononuclear cells. Eur. J. Immunol. 1989; 19: 1079–1085
   Google Scholar
• Waalen K., Sioud M., Natvig J. B., Forre O. Spontaneous in vivo gene transcription of interleukin‐2, interleukin‐3, interleukin‐4, interleukin‐6, interferon gamma, interleukin‐2 receptor (CD25) and proto‐oncogene c‐myc by rheumatoid synovial T lymphocytes. Scan. I. Immunol. 1992; 36: 865–873
   PubMed Web of Science ®Google Scholar
• Smith K. A., Cantrell D. A. Interleukin 2 regulates its own receptors. Proc. Natl Acad. Sci. USA 1985; 82: 864–868
   PubMed Web of Science ®Google Scholar
• Defrance T., Carayon P., Bilhain G., Guillemot J. C., Minty A., Caput D., Ferrara P. Interleukin‐13 is a B cell stimulating factor. J. Exp. Med. 1994; 179: 135–143
   PubMed Web of Science ®Google Scholar
• Rousset F., Garcia E., Defrance T., Peronne C., Vezzio D., Hsu R., Kastelein R., Moore K. W., Banchereau J. Human and viral IL‐10 are potent growth and differentiation factors for activated human B lymphocytes. Proc. Natl Acad. Sci. USA 1991; 89: 1890–1893
   Google Scholar
• Fior R., Vita N., Raphael M., Minty A., Maillot M. C., Crevon M. C., Caput D., Biberfeld P., Ferrara P., Galanaud P., Emilie D. Interleukin 13 gene expression by normal and malignant human B lymphocytes. Blood
   Google Scholar
• Benjamin D., Knobloch T. J., Dayton M. A. Human B‐cell interleukin‐10: Bcell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin‐10. Blood 1992; 81: 1289–1298
   Google Scholar
• Emilie D., Touitou R., Raphael M., Peuchmaur M., Deverqne O., Rea D., Coumbraras J., Crevon M. C., Edelman L., Joab I., Galanaud P. In vivo production of interleukin‐10 by malignant cells in AIDS lymphomas. Eur. J. Immunol. 1992; 22: 2937–2942
   PubMed Web of Science ®Google Scholar
• Talal N., Bunim J. The development of malignant lymphoma in the course of Sjögren's syndrome. Am. J. Med. 1964; 36: 529–540
   PubMed Web of Science ®Google Scholar